Prevalence of Sexually Transmitted Infections Among People Attending the Sexual Assault Centre in Oslo, Norway.

Sponsor
University of Oslo (Other)
Overall Status
Completed
CT.gov ID
NCT03132389
Collaborator
Oslo University Hospital (Other)
640
1
27
23.7

Study Details

Study Description

Brief Summary

In this study the investigators seek to register the prevalence of sexually transmitted infections (STI) among people attending the Sexual Assault Centre in Oslo, Norway. The main aim of this study is to gather representative data on STIs after sexual assaults. Consequently, if the attendance for medical follow up turns out to be good/sufficient, prophylactic (antibiotic) treatment can potentially be omitted.

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention

Detailed Description

Patients who attend sexual assault centres are often concerned about being infected with STIs. Therefore, the patients attending sexual assault centres are offered examination and often receive prophylactic treatment against some STIs (e.g. chlamydia trachomatis, HIV and hepatitis B).

In this study, the investigators seek to register the prevalence of STI among people attending the Sexual Assault Centre in Oslo, Norway. The primary aim of the study is to gather representative data on STIs after a sexual assault. Furthermore, the investigators want to evaluate if there are any variables that can predict transmission after a sexual assult. Results from this study will also be compared with findings of STI in the general population.

At the Sexual Assault Centre in Oslo, Norway, patients are routinely offered three medical follow up consultations. Consequently, if the attendance at follow up visits turns out to be adequate, prophylactic (antibiotic) treatment can potentially be omitted.

Since victims of assault are in a vulnerable situation, it would be useful to be able to inform them more precisely about infection risk and provide adequate prophylactic treatment. More knowledge about the incidence of infection after abuse will increase patient safety and improve the quality of treatment for these patients.

Study Design

Study Type:
Observational
Actual Enrollment :
640 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prevalence of Sexually Transmitted Infections Among People Attending the Sexual Assault Centre in Oslo, Norway: a Cohort Study at the Sexual Assault Centre in Oslo, Norway.
Actual Study Start Date :
May 1, 2017
Actual Primary Completion Date :
Jul 31, 2019
Actual Study Completion Date :
Jul 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Patients attending after a sexual assault

Patients attending and examined after sexual assault at the Sexual Assault Centre in Oslo, who have given informed consent to inclusion in the study.

Other: No intervention
All patients included in the study will be offered the same examination and treatment procedure as the patients who are not included. Identical procedures and examinations will be performed in participants and non-participants.

Outcome Measures

Primary Outcome Measures

  1. Results of the STI-tests taken at the primary examination and at follow up. [1 week]

    Results of the STI-tests (i.e. Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, Hepatitis B, Hepatitis C, HIV, Syphilis) taken at the primary attendance and at follow up.

Secondary Outcome Measures

  1. Attendance percentage for follow up visits. [3 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients attending and examined after sexual assault at the Sexual Assault Centre in Oslo (at Oslo Accident and Emergency Outpatient Clinic).

  • Written informed consent

Exclusion Criteria:
  • Patients who only had a consultation only with a social worker and no medical examination.

  • Unable to communicate in Norwegian, Swedish, Danish or English language

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sexual Assault Centre in Oslo Oslo Norway 0180

Sponsors and Collaborators

  • University of Oslo
  • Oslo University Hospital

Investigators

  • Study Director: Mette Brekke, Professor, University of Oslo

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Odd Martin Vallersnes, Associate professor, University of Oslo
ClinicalTrials.gov Identifier:
NCT03132389
Other Study ID Numbers:
  • 2016/2279/REK
First Posted:
Apr 27, 2017
Last Update Posted:
Mar 25, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Odd Martin Vallersnes, Associate professor, University of Oslo
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 25, 2020